According to IMARC Group’s latest report, titled “Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the global breast lesion localization methods market reached a value of US$ 987.3 Million in 2021. Breast lesion localization methods are a set of various techniques utilized for diagnosing abnormal changes in the breast lesions or breast tissues. Some commonly deployed procedures are radioactive seed localization (RSL), intraoperative ultrasound (IOUS), wire localization, radio-guided occult lesion localization (ROLL), magnetic resonance imaging (MRI), and ultrasound. These methods enable doctors to facilitate suitable treatment and surgery for the patients.
Request for a PDF sample of this report: https://www.imarcgroup.com/breast-lesion-localization-methods-market/requestsample
The increasing prevalence of breast cancer, along with the escalating requirement of lumpectomy and surgical biopsy procedures is one of the key factors primarily driving the market growth. In addition to this, the rising investment and fundings in the research and development (R&D) activities for enhancing biomedical, imaging, surgical, and breast lesion localization procedures are propelling the market growth. Apart from this, the growing demand for cosmetic surgeries, especially breast enhancement, and the numerous initiatives undertaken by the regulatory bodies of various countries for strengthening the healthcare infrastructure are positively stimulating the market growth. Looking forward, IMARC Group expects the market to reach a value of US$ 1,856.70 Million by 2027, exhibiting a CAGR of 10.60% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methodsmarket, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, usage and end user.
Competitive Landscape:
- Argon Medical Devices Inc.
- Becton Dickinson and Company
- Cook Group Incorporated
- CP Medical Inc. (Theragenics Corporation)
- Endomagnetics Ltd.
- Hologic Inc.
- IsoAid LLC
- IZI Medical Products (Landauer Inc)
- Laurane Medical LLC
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- Merit Medical Systems Inc
- Sterylab S.r.l.
Breakup by Type:
- Wire Localization
- Radioisotope Localization
- Magnetic Tracers Localization
- Others
Breakup by Usage:
- Tumor Identification
- Sentinel Lymph Node Identification
- Lumpectomy
- Mastectomy
Breakup by End User:
- Hospitals
- Diagnostic Centres
- Oncology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/breast-lesion-localization-methods-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
